Moreover, the cell growth was significantly inhibited upon anti-IL-6 neutralizing antibody treatment, suggesting that IL-6 provides autocrine growth advantages to the BlCa cell lines (Okamoto et al., 1997). This evidence concerns the gene IL6 and bladder transitional cell carcinoma.